Review



sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit  (GenScript corporation)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Kit Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc11847306-98-18-31
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    In Vitro:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Neutralization:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Virus:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Inhibition:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Binding Assay:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Variant Assay:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Clinical Proteomics:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini

    Incubation:

    Article Title: Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases.
    Article Snippet: The SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) assay (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, USA) was used to detect neutralizing antibodies (NAbs) against the prototype and Omicron variants BA.4/5.

    Article Title: Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant.
    Article Snippet: Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain, delta and Omicron variants) was tested with a SARSCoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, GenScript, Piscataway, NJ, U.S.A.) according to the manufacturer protocol.

    Article Title: Stable SARS-CoV-2 antibody levels and functionality in serum and COVID-19 convalescent plasma after long-term storage.
    Article Snippet: The in vitro functionality of SARSCoV-2 antibodies was examined by the cPassTM SARS-CoV-2 neutralization antibody detection kit (surrogate virus neutralization test [sVNT], GenScript, Piscataway Township, New Jersey, USA) according to the manufacturer’s instructions using an ETIMax3000 device (Diasorin, Saluggia, Italy).

    Article Title: Longitudinal Immunogenicity Study of SARS-CoV-2 mRNA Vaccines Across Subjects with Different Immunocompromising Conditions: Heterogeneity in the Immune Response and Crucial Role of the Booster Dose
    Article Snippet: 144 2.4 ACE2/RBD Binding Inhibition Assay 145 Inhibition of the binding between ACE2 and RBD (Wuhan-Hu-1 strain and Omicron variant) was tested 146 with a SARS-CoV-2 surrogate virus neutralization test (sVNT) kit (cPassTM SARS-CoV-2 Neutralization 147 Antibody Detection Kit, Genscript, Piscataway, NJ, USA) according to the manufacturer protocol, as 148 previously described13.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instructions.

    Article Title: SARS-CoV-2 in Animal Companions: A Serosurvey in Three Regions of Southern Italy.
    Article Snippet: To obtain further confirmation of the specificity of the immune response detected, FRNT-positive serum samples were tested using a surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, Rijswijk, The Netherlands), performed according to the manufacturer’s instruc- Life 2023, 13, 2354 5 of 10 tions.

    Article Title: Serological evidence of SARS-CoV-2 infection in dromedary camels and domestic bovids in Oman.
    Article Snippet: The sera were initially screened for the presence of SARS-CoV-2 antibodies using the surrogate virus neutralization test (sVNT) (GenScript cPassTM SARS-CoV-2 Neutralization Antibody Detection Kit, Genscript, The Netherlands), the test was performed according to the manufacturer’s instructions.

    Article Title: Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.
    Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105577 Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses Annalisa Ciabattini,a,∗ Elena Pettini, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Chiara Coppola, Simone Costagli, Gabiria Pastore, Anna Sicuranza, Monica Tozzi, Arianna Lippi, Francesca Panza, Monica Bocchia, Alessandro Bucalossi, Guido Garosi, David Bennett, Sonia Bernazzali, Massimiliano Fabbiani, Francesca Montagnani, and Donata Medaglini



    Similar Products

    90
    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Kit Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc11847306-98-18-31
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation sarscov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit
    Sarscov 2 Surrogate Virus Neutralization Test (Svnt) Kit Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pm38517153-56-18-31
    Average 90 stars, based on 1 article reviews
    sarscov-2 surrogate virus neutralization test (svnt) kit cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Kit Cpasstm, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pm38675750-64-6-14
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) kit cpasstm - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) kit (cpasstm technology)
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Kit (Cpasstm Technology), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc12016992-140-28-37
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) kit (cpasstm technology) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) kit (cpasstm)
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Kit (Cpasstm), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc10119672-61-0-11
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) kit (cpasstm) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation sars-cov-2 surrogate virus neutralization test (svnt) genscript cpasstm sars-cov-2 neutralization antibody detection kit
    Sars Cov 2 Surrogate Virus Neutralization Test (Svnt) Genscript Cpasstm Sars Cov 2 Neutralization Antibody Detection Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+surrogate+virus+neutralization+test+(svnt)+kit+cpasstm/cpass+sars+cov+2+neutralization+antibody+detection+kit/pmc08831971-63-10-18
    Average 90 stars, based on 1 article reviews
    sars-cov-2 surrogate virus neutralization test (svnt) genscript cpasstm sars-cov-2 neutralization antibody detection kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results